NORTHAMPTON, Mass. — ENDURE week, Sprout Pharmaceuticals resubmitted its medication flibanserin into the Food and Drug management for approval. Flibanserin, when you haven’t heard, is really a drug designed to treat low libido in females. The F.D.A. has refused it twice already, and can most reject that is likely a 3rd time because (if you’re Sprout) the F.D.A. is sexist or (if you’re the F.D.A.) the medication doesn’t work and it isn’t safe.
Nevertheless the biggest issue because of the medication — along with the F.D.A.’s consideration from it — is its backers are trying to treat a thing that is not an ailment.
Flibanserin purportedly treats an ailment called hypoactive desire that is sexual in females. Read more